Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

Arvinas (Nasdaq: ARVN) announced that Chief Medical Officer Noah Berkowitz, M.D., Ph.D. and Chief Financial Officer Andrew Saik will present in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference.

The presentation is scheduled for Thursday, December 4, 2025 at 11:00 a.m. ET in New York. A live audio webcast will be available on the company’s Events and Presentations web page.

NEW HAVEN, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4 at 11:00 a.m. ET in New York.

A live audio webcast of the presentation will be available here and on the Events and Presentations section of the Company’s website.

About Arvinas

Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting Chimera) protein degrader platform, Arvinas is pioneering the development of protein degradation therapies designed to harness the body’s natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative disorders; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic and colorectal cancers; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. Arvinas is headquartered in New Haven, Connecticut. For more information about Arvinas, visit www.arvinas.com and connect on LinkedIn and X.

Contacts
Investors:
Jeff Boyle
+1 (347) 247-5089
Jeff.Boyle@arvinas.com

Media:
Kirsten Owens
+1 (203) 584-0307
Kirsten.Owens@arvinas.com

FAQ

When will Arvinas (ARVN) present at the Piper Sandler 37th Annual Healthcare Conference?

Arvinas will present on December 4, 2025 at 11:00 a.m. ET.

Who from Arvinas will speak at the Piper Sandler conference for ARVN?

Chief Medical Officer Noah Berkowitz, M.D., Ph.D. and Chief Financial Officer Andrew Saik will participate in the fireside chat.

How can investors listen to the Arvinas (ARVN) presentation on December 4, 2025?

A live audio webcast will be available on the company’s Events and Presentations web page.

Where is the Piper Sandler 37th Annual Healthcare Conference taking place for Arvinas' presentation?

The presentation is scheduled to take place in New York as part of the Piper Sandler 37th Annual Healthcare Conference.

Will Arvinas (ARVN) make the presentation recording available after the conference?

The company said the presentation will be available via the Events and Presentations section of its website, where post-event audio is typically posted.

What topics are Arvinas executives likely to cover in the ARVN fireside chat on December 4, 2025?

Executives will discuss recent company developments and outlook; the fireside chat features medical and financial leadership perspectives.